Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106(16):2085–90.
Article
PubMed
Google Scholar
Djaberi R, Beishuizen ED, Pereira AM, Rabelink TJ, Smit JW, Tamsma JT, et al. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia. 2008;51(9):1581–93.
Article
CAS
PubMed Central
PubMed
Google Scholar
Nystrom F, Ekman B, Osterlund M, Lindstrom T, Ohman KP, Arnqvist HJ. Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment. Clin Endocrinol (Oxf). 1997;47(2):191–8.
Article
CAS
Google Scholar
Zhou Y, Rui L. Leptin signaling and leptin resistance. Front Med. 2013;7(2):207–22.
Article
PubMed Central
PubMed
Google Scholar
Jung CH, Kim MS. Molecular mechanisms of central leptin resistance in obesity. Arch Pharm Res. 2013;36(2):201–7.
Article
CAS
PubMed
Google Scholar
Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA. 1999;282(16):1568–75.
Article
CAS
PubMed
Google Scholar
van Dijk G, Donahey JC, Thiele TE, Scheurink AJ, Steffens AB, Wilkinson CW, et al. Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes. 1997;46(11):1911–4.
Article
PubMed
Google Scholar
Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001;14(6 Pt 2):103S–15.
Article
CAS
PubMed
Google Scholar
Haynes WG. Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep. 2000;2(3):311–8.
Article
CAS
PubMed
Google Scholar
Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100(2):270–8.
Article
CAS
PubMed Central
PubMed
Google Scholar
Simonds SE, Pryor JT, Ravussin E, Greenway FL, Dileone R, Allen AM, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159(6):1404–16.
Article
CAS
PubMed Central
PubMed
Google Scholar
Harle P, Straub RH. Leptin is a link between adipose tissue and inflammation. Ann N Y Acad Sci. 2006;1069:454–62.
Article
PubMed
Google Scholar
Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul. 2009;43(4):157–68.
CAS
PubMed
Google Scholar
Viikari LA, Huupponen RK, Viikari JS, Marniemi J, Eklund C, Hurme M, et al. Relationship between leptin and C-reactive protein in young Finnish adults. J Clin Endocrinol Metab. 2007;92(12):4753–8.
Article
CAS
PubMed
Google Scholar
Wijkman M, Lanne T, Engvall J, Lindstrom T, Ostgren CJ, Nystrom FH. Masked nocturnal hypertension–a novel marker of risk in type 2 diabetes. Diabetologia. 2009;52(7):1258–64.
Article
CAS
PubMed
Google Scholar
Fharm E, Cederholm J, Eliasson B, Gudbjornsdottir S, Rolandsson O. Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008. Diabet Med. 2012;29(2):198–206.
Article
CAS
PubMed
Google Scholar
Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008;52(15):1201–10.
Article
CAS
PubMed
Google Scholar
Chen K, Li F, Li J, Cai H, Strom S, Bisello A, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med. 2006;12(4):425–32.
Article
CAS
PubMed
Google Scholar
Lukich A, Gavish D, Shargorodsky M. Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health. Cardiovasc Diabetol. 2014;13(1):141.
Article
PubMed Central
PubMed
Google Scholar
Franks PW, Brage S, Luan J, Ekelund U, Rahman M, Farooqi IS, et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res. 2005;13(8):1476–84.
Article
CAS
PubMed
Google Scholar
Welsh P, Murray HM, Buckley BM, de Craen AJ, Ford I, Jukema JW, et al. Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care. 2009;32(2):308–10.
Article
PubMed Central
PubMed
Google Scholar
Brennan AM, Li TY, Kelesidis I, Gavrila A, Hu FB, Mantzoros CS. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia. 2007;50(6):1178–85.
Article
CAS
PubMed
Google Scholar
Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54.
Article
CAS
PubMed
Google Scholar
Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345–54.
Article
PubMed
Google Scholar
Carnethon MR, Rasmussen-Torvik LJ, Palaniappan L. The obesity paradox in diabetes. Curr Cardiol Rep. 2014;16(2):446.
Article
PubMed
Google Scholar
Shanker J, Rao VS, Ravindran V, Dhanalakshmi B, Hebbagodi S, Kakkar VV. Relationship of adiponectin and leptin to coronary artery disease, classical cardiovascular risk factors and atherothrombotic biomarkers in the IARS cohort. Thromb Haemost. 2012;108(4):769–80.
Article
CAS
PubMed
Google Scholar
Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation. 2001;104(25):3052–6.
Article
CAS
PubMed
Google Scholar
Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med. 1999;246(4):409–18.
Article
CAS
PubMed
Google Scholar
Sattar N, Wannamethee G, Sarwar N, Chernova J, Lawlor DA, Kelly A, et al. Leptin and coronary heart disease: prospective study and systematic review. J Am Coll Cardiol. 2009;53(2):167–75.
Article
CAS
PubMed
Google Scholar
Schottker B, Herder C, Rothenbacher D, Roden M, Kolb H, Muller H, et al. Proinflammatory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care. 2013;36(6):1703–11.
Article
CAS
PubMed Central
PubMed
Google Scholar
Cardoso L, Weinbaum S. Changing views of the biomechanics of vulnerable plaque rupture: a review. Ann Biomed Eng. 2014;42(2):415–31.
Article
PubMed Central
PubMed
Google Scholar
Morioka T, Emoto M, Yamazaki Y, Kawano N, Imamura S, Numaguchi R, et al. Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes. Cardiovasc Diabetol. 2014;13:10.
Article
PubMed Central
PubMed
Google Scholar